{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:16:26Z","timestamp":1784200586639,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010167","name":"Shanghai Shen Kang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR1012B"],"award-info":[{"award-number":["SHDC2020CR1012B"]}],"id":[{"id":"10.13039\/501100010167","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Innovation Plan of Shanghai General Hospital","award":["CTCCR-2018BP03"],"award-info":[{"award-number":["CTCCR-2018BP03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00277-024-05883-w","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T02:01:57Z","timestamp":1720576917000},"page":"3765-3774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies"],"prefix":"10.1007","volume":"103","author":[{"given":"Yanlu","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"4","key":"5883_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMsa1311707","volume":"371","author":"L Gragert","year":"2014","unstructured":"Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M (2014) HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med 371(4):339\u2013348. https:\/\/doi.org\/10.1056\/NEJMsa1311707","journal-title":"N Engl J Med"},{"issue":"1","key":"5883_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood.2023022481","volume":"143","author":"F Thol","year":"2024","unstructured":"Thol F, D\u00f6hner H, Ganser A (2024) How I treat refractory and relapsed acute myeloid leukemia. Blood 143(1):11\u201320. https:\/\/doi.org\/10.1182\/blood.2023022481","journal-title":"Blood"},{"issue":"9","key":"5883_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41408-022-00729-y","volume":"12","author":"K Raj","year":"2022","unstructured":"Raj K, Eikema DJ, Sheth V, Koster L, de Wreede LC, Blaise D, Di Grazia C, Koc Y, Potter V, Chevallier P, Lopez-Corral L, Wu D, Mielke S, Maertens J, Meijer E, Huynh A, Passweg J, Luft T, P\u00e9rez-Sim\u00f3n JA, Ciceri F, Piekarska A, Hayri Ozsan G, Kr\u00f6ger N, Robin M, Yakoub-Agha I (2022) Comparison of outcomes for HLA-matched sibling and haplo-identical donors in myelodysplastic syndromes: report from the chronic malignancies working party of EBMT. Blood Cancer J 12(9):140. https:\/\/doi.org\/10.1038\/s41408-022-00729-y","journal-title":"Blood Cancer J"},{"issue":"4","key":"5883_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.beha.2018.09.012","volume":"31","author":"D Weisdorf","year":"2018","unstructured":"Weisdorf D (2018) Can haploidentical transplantation meet all patients\u2019 needs? Best Pract Res Clin Haematol 31(4):410\u2013413. https:\/\/doi.org\/10.1016\/j.beha.2018.09.012","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"5883_CR5","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1182\/blood.v98.12.3456","volume":"98","author":"L Luznik","year":"2001","unstructured":"Luznik L, Jalla S, Engstrom LW, Iannone R, Fuchs EJ (2001) Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood 98(12):3456\u20133464. https:\/\/doi.org\/10.1182\/blood.v98.12.3456","journal-title":"Blood"},{"issue":"5","key":"5883_CR6","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/cncr.27761","volume":"119","author":"Y Wang","year":"2013","unstructured":"Wang Y, Liu DH, Liu KY, Xu LP, Zhang XH, Han W, Chen H, Chen YH, Wang FR, Wang JZ, Sun YQ, Huang XJ (2013) Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer 119(5):978\u2013985. https:\/\/doi.org\/10.1002\/cncr.27761","journal-title":"Cancer"},{"issue":"1","key":"5883_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","volume":"9","author":"F Malard","year":"2023","unstructured":"Malard F, Holler E, Sandmaier BM, Huang H, Mohty M (2023) Acute graft-versus-host disease. Nat Rev Dis Primers 9(1):27. https:\/\/doi.org\/10.1038\/s41572-023-00438-1","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"5883_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/MOH.0b013e32833eb770","volume":"17","author":"JA Hansen","year":"2010","unstructured":"Hansen JA, Chien JW, Warren EH, Zhao LP, Martin PJ (2010) Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation. Curr Opin Hematol 17(6):483\u2013492. https:\/\/doi.org\/10.1097\/MOH.0b013e32833eb770","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"5883_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/nejm198603203141201","volume":"314","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V et al (1986) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314(12):729\u2013735. https:\/\/doi.org\/10.1056\/nejm198603203141201","journal-title":"N Engl J Med"},{"issue":"6","key":"5883_CR10","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","volume":"73","author":"R Storb","year":"1989","unstructured":"Storb R, Deeg HJ, Pepe M, Appelbaum F, Anasetti C, Beatty P, Bensinger W, Berenson R, Buckner CD, Clift R et al (1989) Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 73(6):1729\u20131734","journal-title":"Blood"},{"issue":"7","key":"5883_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/sj.bmt.1704647","volume":"34","author":"B Bolwell","year":"2004","unstructured":"Bolwell B, Sobecks R, Pohlman B, Andresen S, Rybicki L, Kuczkowski E, Kalaycio M (2004) A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transpl 34(7):621\u2013625. https:\/\/doi.org\/10.1038\/sj.bmt.1704647","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"5883_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21(7):1387\u20131394. https:\/\/doi.org\/10.1038\/sj.leu.2404683","journal-title":"Leukemia"},{"issue":"10","key":"5883_CR13","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1182\/blood.v98.10.2942","volume":"98","author":"A Bacigalupo","year":"2001","unstructured":"Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Barbanti M, Sacchi N, Van Lint MT, Bosi A (2001) Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 98(10):2942\u20132947. https:\/\/doi.org\/10.1182\/blood.v98.10.2942","journal-title":"Blood"},{"issue":"6","key":"5883_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF, Huff CA, Matsui W, Bola\u00f1os-Meade J, Borrello I, Powell JD, Harrington E, Warnock S, Flowers M, Brodsky RA, Sandmaier BM, Storb RF, Jones RJ, Fuchs EJ (2008) HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl 14(6):641\u2013650. https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.005","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"5883_CR15","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/jco.2012.44.3523","volume":"31","author":"A Bashey","year":"2013","unstructured":"Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK, Morris LE, Solomon SR (2013) T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol 31(10):1310\u20131316. https:\/\/doi.org\/10.1200\/jco.2012.44.3523","journal-title":"J Clin Oncol"},{"issue":"1","key":"5883_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-019-0781-y","volume":"12","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wu DP, Liu QF, Xu LP, Liu KY, Zhang XH, Yu WJ, Xu Y, Huang F, Huang XJ (2019) Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients. J Hematol Oncol 12(1):88. https:\/\/doi.org\/10.1186\/s13045-019-0781-y","journal-title":"J Hematol Oncol"},{"issue":"9","key":"5883_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clml.2020.04.003","volume":"20","author":"J El-Cheikh","year":"2020","unstructured":"El-Cheikh J, Devillier R, Dulery R, Massoud R, Al Chami F, Ghaoui N, Moukalled N, Pagliardini T, Marino F, Malard F, Bazarbachi AH, Mohty R, Bazarbachi A, Castagna L, Mohty M, Blaise D (2020) Impact of adding Antithymocyte globulin to Posttransplantation Cyclophosphamide in Haploidentical stem-cell transplantation. Clin Lymphoma Myeloma Leuk 20(9):617\u2013623. https:\/\/doi.org\/10.1016\/j.clml.2020.04.003","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"5883_CR18","doi-asserted-by":"publisher","unstructured":"Wu KH, Weng TF, Li JP, Chao YH (2022) Antithymocyte Globulin Plus Post-transplant Cyclophosphamide Combination as an effective strategy for graft-versus-host Disease Prevention in Haploidentical Peripheral blood stem cell transplantation for children with high-risk malignancies. Pharmaceuticals (Basel) 15(11). https:\/\/doi.org\/10.3390\/ph15111423","DOI":"10.3390\/ph15111423"},{"issue":"7","key":"5883_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41409-018-0382-3","volume":"54","author":"J Yang","year":"2019","unstructured":"Yang J, Jiang J, Cai Y, Li S, Wan L, Zhu J, Liu H, Shao S, Bai H, Wang C, Song X (2019) Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study. Bone Marrow Transpl 54(7):1049\u20131057. https:\/\/doi.org\/10.1038\/s41409-018-0382-3","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"5883_CR20","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1038\/s41409-021-01358-y","volume":"56","author":"X Sun","year":"2021","unstructured":"Sun X, Yang J, Cai Y, Wan L, Huang C, Qiu H, Tong Y, Xu X, Zhou K, Ding X, Song X (2021) Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation. Bone Marrow Transpl 56(10):2423\u20132431. https:\/\/doi.org\/10.1038\/s41409-021-01358-y","journal-title":"Bone Marrow Transpl"},{"key":"5883_CR21","doi-asserted-by":"publisher","first-page":"963689722113910","DOI":"10.1177\/09636897221139103","volume":"31","author":"T Li","year":"2022","unstructured":"Li T, He Q, Yang J, Cai Y, Huang C, Xu X, Qiu H, Niu J, Zhou K, Zhang Y, Xia X, Wei Y, Shen C, Ding X, Tong Y, Wan L, Song X (2022) Low-dose Anti-thymocyte Globulin Plus Low-Dose Posttransplant Cyclophosphamide as an effective regimen for Prophylaxis of Graft Versus host Disease after Haploidentical Peripheral blood stem cell transplantation with Maternal\/Collateral related donors. Cell Transpl 31:9636897221139103. https:\/\/doi.org\/10.1177\/09636897221139103","journal-title":"Cell Transpl"},{"key":"5883_CR22","doi-asserted-by":"publisher","first-page":"1252879","DOI":"10.3389\/fimmu.2023.1252879","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Yang J, Cai Y, Huang C, Xu X, Qiu H, Niu J, Zhou K, Zhang Y, Xia X, Wei Y, Shen C, Tong Y, Dong B, Wan L, Song X (2023) Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study. Front Immunol 14:1252879. https:\/\/doi.org\/10.3389\/fimmu.2023.1252879","journal-title":"Front Immunol"},{"issue":"3","key":"5883_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.beha.2011.05.001","volume":"24","author":"AT Munchel","year":"2011","unstructured":"Munchel AT, Kasamon YL, Fuchs EJ (2011) Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide. Best Pract Res Clin Haematol 24(3):359\u2013368. https:\/\/doi.org\/10.1016\/j.beha.2011.05.001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"5883_CR24","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1182\/blood.v99.12.4364","volume":"99","author":"JW van Esser","year":"2002","unstructured":"van Esser JW, Niesters HG, van der Holt B, Meijer E, Osterhaus AD, Gratama JW, Verdonck LF, L\u00f6wenberg B, Cornelissen JJ (2002) Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 99(12):4364\u20134369. https:\/\/doi.org\/10.1182\/blood.v99.12.4364","journal-title":"Blood"},{"issue":"2","key":"5883_CR25","first-page":"156","volume":"82","author":"G Martinelli","year":"1997","unstructured":"Martinelli G, Trabetti E, Farabegoli P, Testoni N, Bandini G, Motta MR, Vittone A, Terragna C, Pignatti PF, Tura S (1997) Early detection of bone marrow engraftment by amplification of hypervariable DNA regions. Haematologica 82(2):156\u2013160","journal-title":"Haematologica"},{"key":"5883_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-015-0182-9","volume":"8","author":"YJ Chang","year":"2015","unstructured":"Chang YJ, Zhao XY, Xu LP, Zhang XH, Wang Y, Han W, Chen H, Wang FR, Mo XD, Zhang YY, Huo MR, Zhao XS, Liu YK, Huang KY XJ (2015) Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol 8:84. https:\/\/doi.org\/10.1186\/s13045-015-0182-9","journal-title":"J Hematol Oncol"},{"key":"5883_CR27","unstructured":"P D, W D, M P, K HG, B P, H J, T ED (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl 15(6):825\u2013828"},{"issue":"3","key":"5883_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME (2015) National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and Staging Working Group report. Biol Blood Marrow Transpl 21(3):389\u2013401e381. https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001","journal-title":"Biol Blood Marrow Transpl"},{"key":"5883_CR29","doi-asserted-by":"publisher","unstructured":"Br\u00fcggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cav\u00e9 H, Dombret H, Fielding AK, Fo\u00e0 R, G\u00f6kbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ (2010) Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18\u201320 September 2008. Leukemia 24 (3):521\u2013535. https:\/\/doi.org\/10.1038\/leu.2009.268","DOI":"10.1038\/leu.2009.268"},{"issue":"7","key":"5883_CR30","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","volume":"28","author":"A Younes","year":"2017","unstructured":"Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, Seymour JF, Kelly K, Gribben J, Pfreunschuh M, Morschhauser F, Schoder H, Zelenetz AD, Rademaker J, Advani R, Valente N, Fortpied C, Witzig TE, Sehn LH, Engert A, Fisher RI, Zinzani PL, Federico M, Hutchings M, Bollard C, Trneny M, Elsayed YA, Tobinai K, Abramson JS, Fowler N, Goy A, Smith M, Ansell S, Kuruvilla J, Dreyling M, Thieblemont C, Little RF, Aurer I, Van Oers MHJ, Takeshita K, Gopal A, Rule S, de Vos S, Kloos I, Kaminski MS, Meignan M, Schwartz LH, Leonard JP, Schuster SJ, Seshan VE (2017) International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol 28(7):1436\u20131447. https:\/\/doi.org\/10.1093\/annonc\/mdx097","journal-title":"Ann Oncol"},{"key":"5883_CR31","doi-asserted-by":"publisher","unstructured":"Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, Ogana H, Wang W, Lee R, Gang EJ, Khazal S, Kim YM (2020) Minimal residual disease detection in Acute Lymphoblastic Leukemia. Int J Mol Sci 21(3). https:\/\/doi.org\/10.3390\/ijms21031054","DOI":"10.3390\/ijms21031054"},{"key":"5883_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fonc.2019.00726","volume":"9","author":"I Della Starza","year":"2019","unstructured":"Della Starza I, Chiaretti S, De Propris MS, Elia L, Cavalli M, De Novi LA, Soscia R, Messina M, Vitale A, Guarini A, Fo\u00e0 R (2019) Minimal residual disease in Acute Lymphoblastic Leukemia: technical and clinical advances. Front Oncol 9:726. https:\/\/doi.org\/10.3389\/fonc.2019.00726","journal-title":"Front Oncol"},{"issue":"1","key":"5883_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13045-021-01148-5","volume":"14","author":"MJL Aitken","year":"2021","unstructured":"Aitken MJL, Ravandi F, Patel KP, Short NJ (2021) Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia. J Hematol Oncol 14(1):137. https:\/\/doi.org\/10.1186\/s13045-021-01148-5","journal-title":"J Hematol Oncol"},{"issue":"7","key":"5883_CR34","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/cncr.31228","volume":"124","author":"A Ruggeri","year":"2018","unstructured":"Ruggeri A, Labopin M, Bacigalupo A, G\u00fclbas Z, Koc Y, Blaise D, Bruno B, Irrera G, Tischer J, Diez-Martin JL, Castagna L, Ciceri F, Mohty M, Nagler A (2018) Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide. Cancer 124(7):1428\u20131437. https:\/\/doi.org\/10.1002\/cncr.31228","journal-title":"Cancer"},{"issue":"4","key":"5883_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/bmt.2015.305","volume":"51","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri A, Labopin M, Ciceri F, Mohty M, Nagler A (2016) Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission. Bone Marrow Transpl 51(4):610\u2013611. https:\/\/doi.org\/10.1038\/bmt.2015.305","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"5883_CR36","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.exphem.2015.05.008","volume":"43","author":"SS Chaudhury","year":"2015","unstructured":"Chaudhury SS, Morison JK, Gibson BE, Keeshan K (2015) Insights into cell ontogeny, age, and acute myeloid leukemia. Exp Hematol 43(9):745\u2013755. https:\/\/doi.org\/10.1016\/j.exphem.2015.05.008","journal-title":"Exp Hematol"},{"key":"5883_CR37","doi-asserted-by":"publisher","first-page":"794541","DOI":"10.3389\/fped.2021.794541","volume":"9","author":"K Kleinschmidt","year":"2021","unstructured":"Kleinschmidt K, Lv M, Yanir A, Palma J, Lang P, Eyrich M (2021) T-Cell-replete Versus ex vivo T-Cell-depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukaemia and other Haematological malignancies. Front Pediatr 9:794541. https:\/\/doi.org\/10.3389\/fped.2021.794541","journal-title":"Front Pediatr"},{"issue":"8","key":"5883_CR38","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.bbmt.2018.12.007","volume":"25","author":"YJ Xue","year":"2019","unstructured":"Xue YJ, Cheng YF, Lu AD, Wang Y, Zuo YX, Yan CH, Wu J, Sun YQ, Suo P, Chen YH, Chen H, Jia YP, Liu KY, Han W, Xu LP, Zhang LP, Huang XJ (2019) Allogeneic hematopoietic stem cell transplantation, especially haploidentical, May Improve Long-Term Survival for High-Risk Pediatric patients with Philadelphia chromosome-positive Acute Lymphoblastic Leukemia in the tyrosine kinase inhibitor era. Biol Blood Marrow Transpl 25(8):1611\u20131620. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.007","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"5883_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13023-022-02585-2","volume":"17","author":"R Luo","year":"2022","unstructured":"Luo R, Zhang X, Wang Y, Man Q, Gu W, Tian Z, Wang J (2022) Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT. Orphanet J Rare Dis 17(1):422. https:\/\/doi.org\/10.1186\/s13023-022-02585-2","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"5883_CR40","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/mph.0000000000002786","volume":"46","author":"S Arora","year":"2024","unstructured":"Arora S, Thakkar D, Upasana K, Yadav A, Rastogi N, Sharma PS, Yadav SP (2024) Incidence, risk factors, characteristics, and Outcome of Chronic Graft Versus host disease in children undergoing Haploidentical Peripheral Blood Stem Cell Transplant with post-transplant cyclophosphamide. J Pediatr Hematol Oncol 46(1):e44\u2013e50. https:\/\/doi.org\/10.1097\/mph.0000000000002786","journal-title":"J Pediatr Hematol Oncol"},{"issue":"16","key":"5883_CR41","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","volume":"115","author":"L Luznik","year":"2010","unstructured":"Luznik L, Bola\u00f1os-Meade J, Zahurak M, Chen AR, Smith BD, Brodsky R, Huff CA, Borrello I, Matsui W, Powell JD, Kasamon Y, Goodman SN, Hess A, Levitsky HI, Ambinder RF, Jones RJ, Fuchs EJ (2010) High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood 115(16):3224\u20133230. https:\/\/doi.org\/10.1182\/blood-2009-11-251595","journal-title":"Blood"},{"issue":"26","key":"5883_CR42","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1200\/jco.2017.72.8428","volume":"35","author":"A Bashey","year":"2017","unstructured":"Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O\u2019Donnell PV, Perales MA, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M (2017) Mobilized peripheral blood stem cells Versus Unstimulated Bone Marrow as a graft source for T-Cell-replete Haploidentical Donor Transplantation using post-transplant cyclophosphamide. J Clin Oncol 35(26):3002\u20133009. https:\/\/doi.org\/10.1200\/jco.2017.72.8428","journal-title":"J Clin Oncol"},{"issue":"2","key":"5883_CR43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bbmt.2016.11.016","volume":"23","author":"OR Klein","year":"2017","unstructured":"Klein OR, Buddenbaum J, Tucker N, Chen AR, Gamper CJ, Loeb D, Zambidis E, Llosa NJ, Huo JS, Robey N, Holuba MJ, Kasamon YL, McCurdy SR, Ambinder R, Bola\u00f1os-Meade J, Luznik L, Fuchs EJ, Jones RJ, Cooke KR, Symons HJ (2017) Nonmyeloablative haploidentical bone marrow transplantation with Post-transplantation Cyclophosphamide for Pediatric and Young Adult patients with high-risk hematologic malignancies. Biol Blood Marrow Transpl 23(2):325\u2013332. https:\/\/doi.org\/10.1016\/j.bbmt.2016.11.016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"5883_CR44","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.bbmt.2017.08.012","volume":"23","author":"NJ Llosa","year":"2017","unstructured":"Llosa NJ, Cooke KR, Chen AR, Gamper CJ, Klein OR, Zambidis ET, Luber B, Rosner G, Siegel N, Holuba MJ, Robey N, Hayashi M, Jones RJ, Fuchs E, Holdhoff M, Loeb DM, Symons HJ (2017) Reduced-intensity haploidentical bone marrow transplantation with post-transplant cyclophosphamide for solid tumors in Pediatric and Young Adult patients. Biol Blood Marrow Transpl 23(12):2127\u20132136. https:\/\/doi.org\/10.1016\/j.bbmt.2017.08.012","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"5883_CR45","doi-asserted-by":"publisher","first-page":"427e421","DOI":"10.1016\/j.jtct.2021.02.010","volume":"27","author":"\u00c1M Trujillo","year":"2021","unstructured":"Trujillo \u00c1M, Karduss AJ, Suarez G, P\u00e9rez R, Ruiz G, Cardona A, Ram\u00edrez M, Betancur J (2021) Haploidentical hematopoietic stem cell transplantation with Post-transplantation Cyclophosphamide in Children with High-Risk Leukemia using a reduced-intensity conditioning regimen and peripheral blood as the stem cell source. Transpl Cell Ther 27(5):427e421\u2013427e427. https:\/\/doi.org\/10.1016\/j.jtct.2021.02.010","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"5883_CR46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jayao.2016.0060","volume":"6","author":"M Vignon","year":"2017","unstructured":"Vignon M, Andreoli A, Dh\u00e9din N, Lenglin\u00e9 E, Masson E, Robin M, Granier C, Larghero J, Schlageter MH, de Latour RP, Soci\u00e9 G, Boissel N (2017) Graft-versus-host disease in adolescents and young adults (15\u201324 Years Old) after allogeneic hematopoietic stem cell transplantation for Acute Leukemia in First Complete Remission. J Adolesc Young Adult Oncol 6(2):299\u2013306. https:\/\/doi.org\/10.1089\/jayao.2016.0060","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"3","key":"5883_CR47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbmt.2017.11.004","volume":"24","author":"M Qayed","year":"2018","unstructured":"Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljurf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J (2018) Influence of age on Acute and Chronic GVHD in Children undergoing HLA-Identical sibling bone marrow transplantation for Acute Leukemia: implications for Prophylaxis. Biol Blood Marrow Transpl 24(3):521\u2013528. https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.004","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"5883_CR48","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/s1470-2045(17)30417-5","volume":"18","author":"F Locatelli","year":"2017","unstructured":"Locatelli F, Bernardo ME, Bertaina A, Rognoni C, Comoli P, Rovelli A, Pession A, Fagioli F, Favre C, Lanino E, Giorgiani G, Merli P, Pagliara D, Prete A, Zecca M (2017) Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 18(8):1126\u20131136. https:\/\/doi.org\/10.1016\/s1470-2045(17)30417-5","journal-title":"Lancet Oncol"},{"issue":"2","key":"5883_CR49","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/s2352-3026(21)00375-6","volume":"9","author":"R Admiraal","year":"2022","unstructured":"Admiraal R, Nierkens S, Bierings MB, Bredius RGM, van Vliet I, Jiang Y, Lopez-Yurda M, Versluijs AB, Zwaan CM, Lindemans CA, Boelens JJ (2022) Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial. Lancet Haematol 9(2):e111\u2013e120. https:\/\/doi.org\/10.1016\/s2352-3026(21)00375-6","journal-title":"Lancet Haematol"},{"issue":"11","key":"5883_CR50","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1007\/s00277-023-05429-6","volume":"102","author":"Q Wang","year":"2023","unstructured":"Wang Q, Liang Z, Ren H, Dong Y, Yin Y, Wang Q, Liu W, Wang B, Han N, Li Y, Li Y (2023) Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation. Ann Hematol 102(11):3061\u20133074. https:\/\/doi.org\/10.1007\/s00277-023-05429-6","journal-title":"Ann Hematol"},{"issue":"9","key":"5883_CR51","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1200\/jco.2010.31.8121","volume":"29","author":"RB Walter","year":"2011","unstructured":"Walter RB, Gooley TA, Wood BL, Milano F, Fang M, Sorror ML, Estey EH, Salter AI, Lansverk E, Chien JW, Gopal AK, Appelbaum FR, Pagel JM (2011) Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia. J Clin Oncol 29(9):1190\u20131197. https:\/\/doi.org\/10.1200\/jco.2010.31.8121","journal-title":"J Clin Oncol"},{"issue":"4","key":"5883_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s15010-017-1016-1","volume":"45","author":"E Atilla","year":"2017","unstructured":"Atilla E, Atilla PA, Bozda\u011f SC, Demirer T (2017) A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection 45(4):403\u2013411. https:\/\/doi.org\/10.1007\/s15010-017-1016-1","journal-title":"Infection"},{"issue":"8","key":"5883_CR53","doi-asserted-by":"publisher","first-page":"e14098","DOI":"10.1111\/petr.14098","volume":"25","author":"D Atay","year":"2021","unstructured":"Atay D, Akcay A, Yenigurbuz FD, Akinci B, Bagirova K, Hasanova S, Ozturk G (2021) Clinical study of graft-versus-host disease prophylaxis in unrelated hematopoietic stem cell transplantation for pediatric nonmalignant diseases with different doses anti-human T-lymphocyte immunoglobulin. Pediatr Transpl 25(8):e14098. https:\/\/doi.org\/10.1111\/petr.14098","journal-title":"Pediatr Transpl"},{"issue":"3","key":"5883_CR54","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-021-03270-z","volume":"115","author":"K Higuchi","year":"2022","unstructured":"Higuchi K, Sawada A, Kondo O, Okada Y, Tsujimoto H, Ioi A, Mayumi A, Shimizu M, Sato M, Goto K, Inoue S, Yasui M, Inoue M (2022) HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning with very low-dose antithymocyte globulin for relapsed\/refractory acute leukemia in pediatric patients: a single-institution retrospective analysis. Int J Hematol 115(3):406\u2013413. https:\/\/doi.org\/10.1007\/s12185-021-03270-z","journal-title":"Int J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05883-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05883-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05883-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:14:33Z","timestamp":1724836473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05883-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5883"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05883-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of the coordinating institution of Shanghai General Hospital (Code:2022KY023).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}